Trenor Cameron C. III bought ANTX
September 15, 2026 · Form 4 insider transaction
Trenor Cameron C. III bought 116,667 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
116,667
Price
$0.00
Total value
N/A
InsiderTrenor Cameron C. III
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 15, 2026
Filing dateSeptember 16, 2026
Shares owned after116,667
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs") which vest as follows: 10,400 RSUs vest on January 1, 2027, prorated from August 24, 2026, the vesting start date, and the remaining RSUs vest in equal annual installments on each January 1, 2028, January 1, 2029 and January 1, 2030, subject to the Reporting Person's continuous service through each applicable vesting date.